carvedilol has been researched along with Bradyarrhythmia in 11 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Large randomized trials have reported mixed results regarding the risk of bradycardia between metoprolol and carvedilol." | 7.79 | Risk of emergent bradycardia associated with the use of carvedilol and metoprolol in routine clinical practice. ( Pletcher, MJ; Shin, J, 2013) |
| "beta-blockers (BB) in the treatment of heart failure (HF) are frequently underprescribed and underdosed, perhaps because of recommendations for office visits at each dose change." | 5.32 | Remote titration of carvedilol for heart failure patients by advanced practice nurses. ( Mischke, L; Moyer-Knox, D; Mueller, TM; Vuckovic, K; Williams, RE, 2004) |
| "Large randomized trials have reported mixed results regarding the risk of bradycardia between metoprolol and carvedilol." | 3.79 | Risk of emergent bradycardia associated with the use of carvedilol and metoprolol in routine clinical practice. ( Pletcher, MJ; Shin, J, 2013) |
| " Two strategies were evaluated: (1) conventional therapy (conventional)-the risks for death and hospitalization were derived from the angiotensin-converting enzyme inhibitor arm of the SOLVD treatment trial; and (2) pacemaker insertion with atrial pacing and carvedilol therapy (pacemaker-carvedilol)-risk reductions for death and CHF-related hospitalizations for carvedilol compared with conventional therapy were derived from the US Carvedilol Heart Failure Study." | 3.73 | Prophylactic pacemaker use to allow beta-blocker therapy in patients with chronic heart failure with bradycardia. ( Aaronson, KD; Fendrick, AM; Knight, BP; Stecker, EC, 2006) |
| "Beta-blockers substantially improve survival in patients with chronic heart failure (HF) with left ventricular systolic dysfunction, but concerns about cardiovascular adverse effects may deter physicians from prescribing this therapy." | 2.71 | Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials. ( Coffey, CS; Curtis, JP; Foody, JM; Hebert, PR; Ko, DT; Krumholz, HM; Sedrakyan, A, 2004) |
| "Flushing and erythema are frequent skin symptoms in rosacea." | 2.66 | Use of beta-blockers for rosacea-associated facial erythema and flushing: A systematic review and update on proposed mode of action. ( Driessen, RJB; Logger, JGM; Olydam, JI, 2020) |
| "Carvedilol treatment resulted in less left ventricular hypertrophy and dilatation." | 1.37 | Usefulness of carvedilol in the treatment of chronic aortic valve regurgitation. ( Arsenault, M; Couet, J; Lachance, D; Roussel, E; Zendaoui, A, 2011) |
| "beta-blockers (BB) in the treatment of heart failure (HF) are frequently underprescribed and underdosed, perhaps because of recommendations for office visits at each dose change." | 1.32 | Remote titration of carvedilol for heart failure patients by advanced practice nurses. ( Mischke, L; Moyer-Knox, D; Mueller, TM; Vuckovic, K; Williams, RE, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Stone, KH | 1 |
| Reynolds, K | 1 |
| Davis, S | 1 |
| Van Tassell, BW | 1 |
| Gibson, CM | 1 |
| Srivastava, S | 1 |
| Kemnic, T | 1 |
| Hildebrandt, KR | 1 |
| Logger, JGM | 1 |
| Olydam, JI | 1 |
| Driessen, RJB | 1 |
| Shin, J | 1 |
| Pletcher, MJ | 1 |
| Nabeta, T | 1 |
| Inomata, T | 1 |
| Iida, Y | 1 |
| Ikeda, Y | 1 |
| Iwamoto-Ishida, M | 1 |
| Ishii, S | 1 |
| Naruke, T | 1 |
| Mizutani, T | 1 |
| Shinagawa, H | 1 |
| Koitabashi, T | 1 |
| Takeuchi, I | 1 |
| Ako, J | 1 |
| Zendaoui, A | 1 |
| Lachance, D | 1 |
| Roussel, E | 1 |
| Couet, J | 1 |
| Arsenault, M | 1 |
| Cohen-Solal, A | 1 |
| Logeart, D | 1 |
| Guiti, C | 1 |
| Bourgoin, P | 1 |
| Moyer-Knox, D | 1 |
| Mueller, TM | 1 |
| Vuckovic, K | 1 |
| Mischke, L | 1 |
| Williams, RE | 1 |
| Ko, DT | 1 |
| Hebert, PR | 1 |
| Coffey, CS | 1 |
| Curtis, JP | 1 |
| Foody, JM | 1 |
| Sedrakyan, A | 1 |
| Krumholz, HM | 1 |
| Stecker, EC | 1 |
| Fendrick, AM | 1 |
| Knight, BP | 1 |
| Aaronson, KD | 1 |
1 review available for carvedilol and Bradyarrhythmia
| Article | Year |
|---|---|
Use of beta-blockers for rosacea-associated facial erythema and flushing: A systematic review and update on proposed mode of action.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Bradycardia; Carvedilol; Dermatologic Agents; Dru | 2020 |
1 trial available for carvedilol and Bradyarrhythmia
| Article | Year |
|---|---|
Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Bradycardia; Carbazoles; Carvedilol; Dizziness; Fatig | 2004 |
9 other studies available for carvedilol and Bradyarrhythmia
| Article | Year |
|---|---|
Comparison of new-onset post-operative atrial fibrillation between patients receiving carvedilol and metoprolol after off-pump coronary artery bypass graft surgery.
Topics: Adrenergic beta-Antagonists; Adult; Atrial Fibrillation; Bradycardia; Carvedilol; Coronary Artery By | 2023 |
BRASH syndrome.
Topics: Antihypertensive Agents; Atrioventricular Block; Bradycardia; Bumetanide; Carvedilol; Female; Humans | 2020 |
Risk of emergent bradycardia associated with the use of carvedilol and metoprolol in routine clinical practice.
Topics: Adrenergic alpha-1 Receptor Antagonists; Bradycardia; California; Carbazoles; Carvedilol; Comorbidit | 2013 |
Prognostic significance of beta-blocker up-titration in conjunction with cardiac resynchronization therapy in heart failure management.
Topics: Adrenergic beta-Antagonists; Aged; Blood Pressure; Bradycardia; Carbazoles; Cardiac Resynchronizatio | 2016 |
Usefulness of carvedilol in the treatment of chronic aortic valve regurgitation.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Animals; Aortic Valve Insufficiency; Atrial Natri | 2011 |
[Use of carvedilol in daily practice].
Topics: Adrenergic beta-Antagonists; Bradycardia; Carbazoles; Cardiology; Carvedilol; Coronary Disease; Drug | 1999 |
Remote titration of carvedilol for heart failure patients by advanced practice nurses.
Topics: Adrenergic beta-Antagonists; Aged; Bradycardia; Carbazoles; Carvedilol; Clinical Protocols; Cohort S | 2004 |
Prophylactic pacemaker use to allow beta-blocker therapy in patients with chronic heart failure with bradycardia.
Topics: Adrenergic beta-Antagonists; Bradycardia; Carbazoles; Carvedilol; Comorbidity; Cost-Benefit Analysis | 2006 |
Beta-blockers for heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Bradycardia; Carbazoles; Carvedilol; Heart Failure; Humans; | 2000 |